+++ NEWS - gerade noch rechtzeitig .. +++ - 500 Beiträge pro Seite
eröffnet am 23.12.04 15:38:21 von
neuester Beitrag 23.12.04 21:10:16 von
neuester Beitrag 23.12.04 21:10:16 von
Beiträge: 11
ID: 938.553
ID: 938.553
Aufrufe heute: 0
Gesamt: 910
Gesamt: 910
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
02.05.24, 18:44 | 628 | |
01.05.24, 18:36 | 155 | |
gestern 22:26 | 132 | |
gestern 22:59 | 118 | |
vor 46 Minuten | 93 | |
gestern 22:11 | 93 | |
heute 00:47 | 79 | |
heute 00:50 | 71 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 181,19 | +0,66 | 95 | |||
2. | 2. | 18.058,00 | +0,07 | 78 | |||
3. | 3. | 0,1865 | 0,00 | 43 | |||
4. | 4. | 2.305,34 | +0,12 | 26 | |||
5. | 5. | 0,1535 | 0,00 | 23 | |||
6. | 6. | 0,0775 | 0,00 | 23 | |||
7. | 8. | 38.670,25 | +1,19 | 16 | |||
8. | 9. | 9,7000 | +12,27 | 15 |
rein bis 0.55
OTC-Wert agreement mit Johnson & Johnson
Quick-Med Technologies, Inc. Signs Research Agreement with Johnson & Johnson Wound Management
GAINESVILLE, Fla.--(BUSINESS WIRE)--Dec. 23, 2004--Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today that it has entered into a six-month research agreement with Johnson & Johnson Wound Management, a division of ETHICON INC., a Johnson & Johnson company, to investigate applications of their NIMBUS(TM) antimicrobial technology to advanced wound care products.
"We are very pleased to be collaborating with Johnson & Johnson Wound Management," said Mr. David S. Lerner, President of Quick-Med Technologies. "This collaboration is another validation of the capabilities of our NIMBUS(TM) technology." added Mr. Lerner.
The specific terms of the agreement were not disclosed.
About Quick-Med Technologies, Inc.
Quick-Med Technologies is a life sciences company focused on developing proprietary, broad-based technologies for consumer, industrial, and healthcare use, as well as for advanced military and civilian medical applications. The Company`s two core products under development are: (1) MultiStat(TM), a family of advanced compounds shown to be effective in broad-based skin therapy applications; and (2) NIMBUS(TM), a family of advanced polymers that can be used in a wide range of applications from advanced wound care to industrial and consumer preservatives. Quick-Med Technologies is listed under the symbol "QMDT" on the OTC Bulletin Board. For additional information, visit Quick-Med Technologies` website: http://www.quickmedtech.com or email: info@quickmedtech.com for further information.
Certain statements in this press release constitute "forward-looking statements". Such forward-looking statements involve known and unknown risks, certainties and other factors, which may cause the actual results, performance of achievements of Quick-Med Technologies, Inc. (the "Company") to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. There is no assurance that the Company will complete any transactions, whether with Johnson & Johnson Wound Management or otherwise. The signing of an agreement with Johnson & Johnson Wound Management should not be construed by any means as an indication of the Company`s future financial performance or the future value of its common stock. Furthermore, the Company`s future operating results are dependent upon many factors, including whether the Company will ever successfully launch its potential technologies and/or products and the risk factors contained in its periodic and other filings, which are available for review at www.sec.gov. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events, or circumstances after the date of such statement.
CONTACT: Quick-Med Technologies, Inc.
David S. Lerner, 561-750-4202
Email: dlerner@quickmedtech.com
or
Investor Relations, 403-203-4748
Email: info@quickmedtech.com
Website: www.quickmedtech.com
SOURCE: Quick-Med Technologies, Inc.
OTC-Wert agreement mit Johnson & Johnson
Quick-Med Technologies, Inc. Signs Research Agreement with Johnson & Johnson Wound Management
GAINESVILLE, Fla.--(BUSINESS WIRE)--Dec. 23, 2004--Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today that it has entered into a six-month research agreement with Johnson & Johnson Wound Management, a division of ETHICON INC., a Johnson & Johnson company, to investigate applications of their NIMBUS(TM) antimicrobial technology to advanced wound care products.
"We are very pleased to be collaborating with Johnson & Johnson Wound Management," said Mr. David S. Lerner, President of Quick-Med Technologies. "This collaboration is another validation of the capabilities of our NIMBUS(TM) technology." added Mr. Lerner.
The specific terms of the agreement were not disclosed.
About Quick-Med Technologies, Inc.
Quick-Med Technologies is a life sciences company focused on developing proprietary, broad-based technologies for consumer, industrial, and healthcare use, as well as for advanced military and civilian medical applications. The Company`s two core products under development are: (1) MultiStat(TM), a family of advanced compounds shown to be effective in broad-based skin therapy applications; and (2) NIMBUS(TM), a family of advanced polymers that can be used in a wide range of applications from advanced wound care to industrial and consumer preservatives. Quick-Med Technologies is listed under the symbol "QMDT" on the OTC Bulletin Board. For additional information, visit Quick-Med Technologies` website: http://www.quickmedtech.com or email: info@quickmedtech.com for further information.
Certain statements in this press release constitute "forward-looking statements". Such forward-looking statements involve known and unknown risks, certainties and other factors, which may cause the actual results, performance of achievements of Quick-Med Technologies, Inc. (the "Company") to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. There is no assurance that the Company will complete any transactions, whether with Johnson & Johnson Wound Management or otherwise. The signing of an agreement with Johnson & Johnson Wound Management should not be construed by any means as an indication of the Company`s future financial performance or the future value of its common stock. Furthermore, the Company`s future operating results are dependent upon many factors, including whether the Company will ever successfully launch its potential technologies and/or products and the risk factors contained in its periodic and other filings, which are available for review at www.sec.gov. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events, or circumstances after the date of such statement.
CONTACT: Quick-Med Technologies, Inc.
David S. Lerner, 561-750-4202
Email: dlerner@quickmedtech.com
or
Investor Relations, 403-203-4748
Email: info@quickmedtech.com
Website: www.quickmedtech.com
SOURCE: Quick-Med Technologies, Inc.
Nur in USA handelbar
ISIN US74837Q1067
ISIN US74837Q1067
McG, alter Pusher,
ich seh schon, Du bleibst Dir treu!
Frohes Fest für Dich & Family
Michi
ich seh schon, Du bleibst Dir treu!
Frohes Fest für Dich & Family
Michi
MMID Bid Bid Size MMID Ask Ask Size
QMDT Bullet Quote PulseChart
SCHB 0.500 50 TDCM 0.530 25
JPTC 0.450 50 FRAN 0.540 25
NITE 0.450 50 BAMM 0.550 25
TDCM 0.350 50 NITE 0.550 25
JEFF 0.300 50 HDSN 0.600 25
GVRC 0.280 50 SCHB 0.600 25
FRAN 0.260 50 SACM 0.600 25
VERT 0.260 50 HILL 0.700 25
CRWN 0.250 50 JPTC 0.900 25
VFIN 0.250 50 VNDM 1.000 25
VNDM 0.240 50 BWNC 1.010 5
HILL 0.120 50 PERT 1.010 5
PERT 0.080 50 STCS 1.010 5
SACM 0.080 50 VERT 1.010 5
HDSN 0.050 50 JEFF 1.010 5
BAMM 0.025 50 CRWN 1.020 5
BWNC 0.010 50 GVRC 1.050 5
STCS 0.010 50 VFIN 1.300 5
GNET 0.000 0 GNET 0.000 0
Orderbuch 15 min verspätet
Kurs im Moment 0.67 34 % Plus - Hoch war bereits bei 0.70
QMDT Bullet Quote PulseChart
SCHB 0.500 50 TDCM 0.530 25
JPTC 0.450 50 FRAN 0.540 25
NITE 0.450 50 BAMM 0.550 25
TDCM 0.350 50 NITE 0.550 25
JEFF 0.300 50 HDSN 0.600 25
GVRC 0.280 50 SCHB 0.600 25
FRAN 0.260 50 SACM 0.600 25
VERT 0.260 50 HILL 0.700 25
CRWN 0.250 50 JPTC 0.900 25
VFIN 0.250 50 VNDM 1.000 25
VNDM 0.240 50 BWNC 1.010 5
HILL 0.120 50 PERT 1.010 5
PERT 0.080 50 STCS 1.010 5
SACM 0.080 50 VERT 1.010 5
HDSN 0.050 50 JEFF 1.010 5
BAMM 0.025 50 CRWN 1.020 5
BWNC 0.010 50 GVRC 1.050 5
STCS 0.010 50 VFIN 1.300 5
GNET 0.000 0 GNET 0.000 0
Orderbuch 15 min verspätet
Kurs im Moment 0.67 34 % Plus - Hoch war bereits bei 0.70
MMID Bid Bid Size MMID Ask Ask Size
QMDT Bullet Quote PulseChart
FRAN 0.600 25 HILL 0.700 25
TDCM 0.600 25 FRAN 0.740 25
VFIN 0.580 25 NITE 0.800 25
NITE 0.580 25 SCHB 0.805 25
JPTC 0.550 25 JPTC 0.900 25
SCHB 0.550 25 VNDM 1.000 25
BAMM 0.540 25 BWNC 1.010 5
JEFF 0.300 50 PERT 1.010 5
SACM 0.300 50 STCS 1.010 5
GVRC 0.280 50 VERT 1.010 5
VERT 0.260 50 JEFF 1.010 5
CRWN 0.250 50 BAMM 1.010 5
VNDM 0.240 50 TDCM 1.010 5
HILL 0.120 50 CRWN 1.020 5
PERT 0.080 50 HDSN 1.020 5
HDSN 0.050 50 GVRC 1.050 5
BWNC 0.010 50 SACM 1.200 5
STCS 0.010 50 VFIN 1.300 5
Laßt da mal etwas mehr Umsatz reinkommen
QMDT Bullet Quote PulseChart
FRAN 0.600 25 HILL 0.700 25
TDCM 0.600 25 FRAN 0.740 25
VFIN 0.580 25 NITE 0.800 25
NITE 0.580 25 SCHB 0.805 25
JPTC 0.550 25 JPTC 0.900 25
SCHB 0.550 25 VNDM 1.000 25
BAMM 0.540 25 BWNC 1.010 5
JEFF 0.300 50 PERT 1.010 5
SACM 0.300 50 STCS 1.010 5
GVRC 0.280 50 VERT 1.010 5
VERT 0.260 50 JEFF 1.010 5
CRWN 0.250 50 BAMM 1.010 5
VNDM 0.240 50 TDCM 1.010 5
HILL 0.120 50 CRWN 1.020 5
PERT 0.080 50 HDSN 1.020 5
HDSN 0.050 50 GVRC 1.050 5
BWNC 0.010 50 SACM 1.200 5
STCS 0.010 50 VFIN 1.300 5
Laßt da mal etwas mehr Umsatz reinkommen
http://agora-direct.de/
Realtimekurse aller USA-Börsen
zusammen für nur 10 USD im Monat tick-
und sekundengenau
für Vieltrader auch vollständig kostenfrei
oder
http://agora-direct.de/index.php?action=preise
Realtimekurse aller USA-Börsen
zusammen für nur 10 USD im Monat tick-
und sekundengenau
für Vieltrader auch vollständig kostenfrei
oder
http://agora-direct.de/index.php?action=preise
Packen wir heut noch den Dollar
MMID Bid Bid Size MMID Ask Ask Size
QMDT Bullet Quote PulseChart
HILL 0.620 25 SCHB 0.670 25
TDCM 0.600 25 GNET 0.750 25
NITE 0.580 25 NITE 0.800 25
JPTC 0.580 25 JPTC 0.900 25
SCHB 0.550 25 FRAN 0.950 25
FRAN 0.550 25 VNDM 1.000 25
VFIN 0.550 25 BWNC 1.010 5
BAMM 0.540 25 PERT 1.010 5
JEFF 0.300 50 STCS 1.010 5
SACM 0.300 50 VERT 1.010 5
GVRC 0.280 50 JEFF 1.010 5
VERT 0.260 50 BAMM 1.010 5
CRWN 0.250 50 TDCM 1.010 5
VNDM 0.240 50 HILL 1.010 5
PERT 0.080 50 CRWN 1.020 5
HDSN 0.050 50 HDSN 1.020 5
BWNC 0.010 50 GVRC 1.050 5
STCS 0.010 50 SACM 1.200 5
GNET 0.000 0 VFIN 1.300 5
MMID Bid Bid Size MMID Ask Ask Size
QMDT Bullet Quote PulseChart
HILL 0.620 25 SCHB 0.670 25
TDCM 0.600 25 GNET 0.750 25
NITE 0.580 25 NITE 0.800 25
JPTC 0.580 25 JPTC 0.900 25
SCHB 0.550 25 FRAN 0.950 25
FRAN 0.550 25 VNDM 1.000 25
VFIN 0.550 25 BWNC 1.010 5
BAMM 0.540 25 PERT 1.010 5
JEFF 0.300 50 STCS 1.010 5
SACM 0.300 50 VERT 1.010 5
GVRC 0.280 50 JEFF 1.010 5
VERT 0.260 50 BAMM 1.010 5
CRWN 0.250 50 TDCM 1.010 5
VNDM 0.240 50 HILL 1.010 5
PERT 0.080 50 CRWN 1.020 5
HDSN 0.050 50 HDSN 1.020 5
BWNC 0.010 50 GVRC 1.050 5
STCS 0.010 50 SACM 1.200 5
GNET 0.000 0 VFIN 1.300 5
Wieder 17.500k aus dem ASK - geht wieder los - keiner verkauft auf dem Niveau
ASK kurz hoch auf 0.75 - da sieht man - keine Shares - jetzt wieder 0.67 Plus 34 %.
Denke mal mit etwas Umsatz knacken wir den Dollar
Übrigens AVTX - Hammer-Orderbuch - paar Trades = 50 %
ASK kurz hoch auf 0.75 - da sieht man - keine Shares - jetzt wieder 0.67 Plus 34 %.
Denke mal mit etwas Umsatz knacken wir den Dollar
Übrigens AVTX - Hammer-Orderbuch - paar Trades = 50 %
ASK 0.75
46 %
0.74 = 48 %
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
96 | ||
78 | ||
43 | ||
28 | ||
23 | ||
23 | ||
16 | ||
16 | ||
15 | ||
14 |
Wertpapier | Beiträge | |
---|---|---|
14 | ||
11 | ||
9 | ||
6 | ||
6 | ||
6 | ||
6 | ||
6 | ||
6 | ||
5 |